EUVIMEDEUVIMED entdecken
Crossref

Therapeutic potential of Lacticaseibacillus rhamnosus grx10 and its derived postbiotic through gut microbiota and MAPK/MLCK/MLC pathway‐mediated intestinal barrier repairment in ulcerative colitis

Huilan Ye iD, Xiaolin Liu, Kaifang Guan, Ying Ma, Rongmei Liu, Yuxuan Liu, Xuepeng Lv, Rongchun Wang iD, Qiming Li

Journal of Food Science · 2024

DOI: 10.1111/1750-3841.17550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Science, 2024. Verfasst von Huilan Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Harbin Institute of Technology, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Lacticaseibacillus rhamnosus, Colitis, Ulcerative, Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Science and Technology Planning Project of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lacticaseibacillus rhamnosus grx10 (grx10) has shown promising potential in promoting intestinal health as predicted by genomic and metabolomic analyses. Given the increasing prevalence of ulcerative colitis (UC) and the limitations of existing treatments, exploring alternative therapeutic strategies is essential. This study explored the therapeutic effects and underlying mechanisms of grx10 and its derived postbiotic (P‐grx10) in a mouse model of dextran sulfate sodium (DSS)‐induced chronic UC. The intervention with grx10 and P‐grx10 significantly alleviated clinical symptoms and improved biochemical markers in UC mice. These effects included reducing the disease activity index (DAI), improving colon length and histopathological damage, decreasing the secretion of inflammatory cytokines, and preventing the reduction of antioxidant enzymes. Additionally, grx10 and P‐grx10 downregulated key proteins in the Mitogen‐Activated Protein Kinase (MAPK)/myosin light chain kinase (MLCK)/myosin light chain (MLC) pathway, prevented the dissociation of tight junction (TJ) proteins and E‐cadherin, reduced intestinal permeability, and restored the integrity of the intestinal barrier. Furthermore, both grx10 and P‐grx10 modulated the composition and abundance of gut microbiota, helping to maintain intestinal microbiome homeostasis. In conclusion, this study provided evidence regarding the role of grx10 and P‐grx10 in alleviating intestinal barrier dysfunction associated with UC and restoring gut microbiota balance. Notably, P‐grx10 exhibited higher anti‐inflammatory activity and better restoration of intestinal barrier function, whereas the live probiotic grx10 showed a stronger regulatory effect on the gut microbiota. These findings suggest that grx10 and P‐grx10 could serve as promising nutritional adjunct therapies for UC, providing novel insights into the distinct roles of probiotic and its derived postbiotic in UC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lacticaseibacillus rhamnosusColitis, UlcerativeGastrointestinal MicrobiomeProbioticsMyosin-Light-Chain KinaseDextran SulfateAnimalsMiceMaleDisease Models, AnimalMice, Inbred C57BLIntestinal MucosaMitogen-Activated Protein KinasesColonCytokinesTight Junction Proteins

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosusgut microbiotaintestinal barrierpostbioticsulcerative colitis

Substanzen

Myosin-Light-Chain KinaseDextran SulfateMitogen-Activated Protein KinasesCytokinesTight Junction Proteins

Autor:innen und Institutionen

  • School of Medicine and Health, Harbin Institute of Technology, Harbin, Heilongjiang, China.
  • School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin, Heilongjiang, China.
  • Dairy Nutrition and Function, Key Laboratory of Sichuan Province, New Hope Dairy Co., Ltd, Chengdu, Sichuan, China.
  • Chengdu Molecular Power Biotechnology Co., Ltd, Chengdu, Sichuan, China.
  • National Center of Technology Innovation for Dairy, Hohhot, Inner Mongolia, China.

ORCID-Profile: Huilan Ye, Rongchun Wang

Förderung

  • Science and Technology Planning Project of Sichuan Province

Zitieren

APA

Ye, H., Liu, X., Guan, K., Ma, Y., Liu, R., Liu, Y., Lv, X., Wang, R., & Li, Q. (2024). Therapeutic potential of Lacticaseibacillus rhamnosus grx10 and its derived postbiotic through gut microbiota and MAPK/MLCK/MLC pathway‐mediated intestinal barrier repairment in ulcerative colitis. Journal of Food Science. https://doi.org/10.1111/1750-3841.17550

Vancouver

Ye H, Liu X, Guan K, Ma Y, Liu R, Liu Y, et al. Therapeutic potential of Lacticaseibacillus rhamnosus grx10 and its derived postbiotic through gut microbiota and MAPK/MLCK/MLC pathway‐mediated intestinal barrier repairment in ulcerative colitis. Journal of Food Science. 2024. doi:10.1111/1750-3841.17550

BibTeX
@article{Ye2024,
  author = {Ye, Huilan and Liu, Xiaolin and Guan, Kaifang and Ma, Ying and Liu, Rongmei and Liu, Yuxuan and Lv, Xuepeng and Wang, Rongchun and Li, Qiming},
  title = {Therapeutic potential of Lacticaseibacillus rhamnosus grx10 and its derived postbiotic through gut microbiota and MAPK/MLCK/MLC pathway‐mediated intestinal barrier repairment in ulcerative colitis},
  journal = {Journal of Food Science},
  year = {2024},
  doi = {10.1111/1750-3841.17550}
}
Kostenlos starten →